Plain-English translation of NCT07204561 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether CeraVe, a moisturizing cream, can help keep atopic dermatitis (eczema) under control once it has been cleared with steroid treatment. The study will compare this medication to a standard moisturizer that doctors commonly prescribe, to see which one is better at preventing the eczema from coming back and keeping the skin hydrated.
Eczema is a chronic skin condition where the skin barrier doesn't work properly and doesn't retain moisture well. While steroids can clear up flare-ups, patients need a good maintenance plan afterward—and this treatment has not been formally studied yet to prove how effective it is at this stage.
You likely qualify if…
You likely don't qualify if…
After your eczema clears with steroid treatment, you will be randomly assigned to use either CeraVe moisturizing cream or a standard prescription moisturizer twice daily as maintenance. You'll keep a diary of any symptoms, use a provided gentle cleanser, and come in for check-ups. If your eczema flares up again, you'll exit the study and receive appropriate medical care from your doctor.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy
Sponsor
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Enrollment target
~98 participants
Started
March 2025
Primary completion
July 2026
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Prof.ssa Elena Campione
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.